Mutual of America Capital Management LLC Decreases Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Mutual of America Capital Management LLC lessened its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2.7% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 54,853 shares of the company’s stock after selling 1,496 shares during the quarter. Mutual of America Capital Management LLC’s holdings in GE HealthCare Technologies were worth $4,288,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of GEHC. Farther Finance Advisors LLC increased its position in shares of GE HealthCare Technologies by 10.9% in the third quarter. Farther Finance Advisors LLC now owns 4,520 shares of the company’s stock worth $424,000 after acquiring an additional 443 shares in the last quarter. Janney Montgomery Scott LLC acquired a new stake in GE HealthCare Technologies in the 3rd quarter valued at $4,367,000. Forum Financial Management LP raised its position in GE HealthCare Technologies by 5.4% in the third quarter. Forum Financial Management LP now owns 6,084 shares of the company’s stock valued at $571,000 after purchasing an additional 314 shares during the period. Intact Investment Management Inc. acquired a new position in shares of GE HealthCare Technologies during the third quarter worth about $73,000. Finally, National Pension Service lifted its stake in shares of GE HealthCare Technologies by 15.8% during the third quarter. National Pension Service now owns 716,002 shares of the company’s stock worth $67,197,000 after purchasing an additional 97,826 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently commented on GEHC. Citigroup raised their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, February 13th. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their price objective for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. Finally, Wells Fargo & Company boosted their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. One analyst has rated the stock with a sell rating, three have given a hold rating, eight have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and an average price target of $97.67.

GE HealthCare Technologies Stock Down 2.5 %

Shares of NASDAQ:GEHC opened at $84.31 on Wednesday. The firm has a market cap of $38.55 billion, a PE ratio of 19.47, a price-to-earnings-growth ratio of 3.19 and a beta of 1.15. The company has a fifty day simple moving average of $86.41 and a 200 day simple moving average of $86.14. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. GE HealthCare Technologies Inc. has a 12-month low of $74.51 and a 12-month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The company had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. On average, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.